Friday, 28 January, 2022
TopicLancet study

Topic: Lancet study

Covid booster dose offers effective antibody protection against Omicron, Lancet study finds

The study found that the overall antibody levels were nearly 2.5 times higher against Omicron after three doses of Coved vaccine as compared to after two jabs.

Children with poorly controlled asthma need Covid vaccine on priority, study in Lancet says

The study says children aged 5–17 years with poorly controlled asthma are at higher risk of Covid-19 hospital admission compared with those without asthma.

Drug to treat OCD could reduce hospitalisation risk in Covid patients, study in Lancet says

The study says antidepressant fluvoxamine could reduce the production of inflammatory molecules called cytokines that can be triggered by SARS-CoV-2 infection.

Risk of hospitalisation doubles with Delta variant compared to Alpha, study in Lancet says

The study is the first to report hospitalisation risk for the Delta vs Alpha variants based on cases confirmed by whole-genome sequencing, the most accurate way to determine the virus variant.

Increased risk of heart attack, stroke in first 2 weeks of Covid, Lancet study finds

The study compared the occurrence of acute myocardial infarction or heart attack, and stroke in 86,742 Covid patients with 348,481 control individuals in Sweden.

BioNTech vaccine creates 10 times higher antibody levels compared to Sinovac: Study in Lancet

Researchers noted that antibody concentrations for BioNTech recipients rose 'substantially' after first dose, but Sinovac recipients showed 'low' level of antibodies after first shot.

Alcohol drinking associated with 62,100 cancer cases in India last year, says Lancet study

The study highlights the contribution of even relatively low levels of drinking to rates of cancer but suggests that small changes to drinking behaviour can have a positive impact.

Pfizer, AstraZeneca vaccines provide ‘good protection’ against Delta variant: Lancet study

The study finds Pfizer's Covid vaccine offers 79 per cent protection and the AstraZeneca vaccine, known as Covishield in India, secures 60 per cent protection against Covid strain.

No substantial evidence to say kids will be more affected in 3rd Covid wave –– Lancet report

As per the data, mortality rates among hospitalised Covid-19 positive children below 10 years of age was 2.4 percent; about 40 percent children who died had comorbidities.

Migraine, breathing issues could stay briefly after mild Covid, serious problems unlikely: Lancet

Persistent symptoms such as breathing issues & migraines may lead to increased visits to doctors in 6 months following Covid infection, the study found.

On Camera


Covid isn’t behind us, but the world’s next big health emergency is already here

Covid has led to 5.6 million deaths, but antimicrobial resistance is likely to log 10 million deaths annually by 2050. Its treatment has led to antibiotics' overuse, which has spiked drug resistance.
An Assicurazioni Generali SpA logo sits above an entrance to their offices in Rome | Bloomberg

Italian Generali buys 25% stake worth Rs 1,250 cr in insurance JV from embattled Future Group

The stake sale, which will give Generali majority control over the JV, comes as the Future Group is locked in a prolonged legal battle with partner Amazon.


The Indian Army's Akash missiles on display during the 73rd Republic Day Parade, at Rajpath, in New Delhi | ANI

Not just 1st R-Day, 26 Jan 1950 also significant as Indian Army, Navy shed ‘Royal’ prefix

Both the ‘Royal’ prefix for the Navy and Air Force in India, as well as the absence of such a label for the Army, have their roots in British military and political history.

Modi vs non-BJP CMs: When most popular isn’t all-powerful & why Centre-state ties will worsen

Modi’s inability to win many states, and the huge popularity his rivals enjoy there, is pushing Indian politics in a more robustly federal direction.